Evaluating dopamine transporter imaging as an enrichment biomarker in a phase 2 Parkinson's disease trial. Alzforum, 26 Nov 2021 Hutchison RM, Evans KC, Fox T, Yang M, Barakos J, Bedell BJ, Cedarbaum JM, Brys M, Siderowf A, Lang AE.